Join
Live feed
·
INSIDERFilingvia Quantisnow
Centessa Pharmaceuticals plc logo

Chief Executive Officer Accardi Mario Alberto returned 243,282 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
CNTA· Centessa Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTA (Centessa Pharmaceuticals plc) and more on Quantisnow.